RedHill Biopharma (RDHL) Earnings Analysis
RedHill Biopharma (RDHL) next reports earnings on 2026-08-20, consensus EPS -435 USD. Last quarter (2025-09-05) it beat with EPS -1 USD vs -690 USD est (+99.9%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RDHL next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | -435 USD |
| Revenue estimate | 0.02B |
RDHL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-05 | -1 USD | -690 USD | +99.9% | Beat |
| 2025-04-10 | -1 USD | -690 USD | +99.9% | Beat |
| 2024-10-03 | 9 USD | -3.68 USD | +344.6% | Beat |
| 2024-07-29 | -2 USD | -0.3 USD | -566.7% | Miss |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
RDHL valuation and analyst view
| Trailing P/E | -0.34 |
|---|---|
| Trailing EPS | -2.29229 USD |
| Price / book | 0.29 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (10 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is RedHill Biopharma (RDHL)'s next earnings date?
RedHill Biopharma is next scheduled to report on 2026-08-20, with a consensus EPS estimate of -435 USD and revenue estimate of 0.02B.
Did RDHL beat earnings last quarter?
In its 2025-09-05 report, RDHL posted EPS of -1 USD versus a -690 USD estimate — a beat of 99.9%.
What is RDHL's earnings track record?
Over the last 4 reported quarters with consensus data, RDHL beat estimates 3 times (75%).
What is RDHL's current P/E ratio and EPS?
RDHL trades at a trailing P/E of -0.34 on trailing EPS of -2.2922880839843773 USD.
What do analysts rate RDHL?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell).